As of Q2'26 (2025-11-30), Nike's latest reported SG&A Expenses stand at USD 4.04B, while R&D Expenses remain at USD 0. This indicates that the company's operating expenses are almost entirely driven by SG&A costs, with no allocation to R&D over the period shown. From Q3'23 to Q2'26, SG&A Expenses have fluctuated within a relatively narrow range, peaking at USD 4.37B in Q4'23 and reaching a low of USD 3.89B in Q3'25. The trend shows modest volatility but no significant long-term growth or decline, suggesting stable cost management. R&D Expenses consistently register at zero throughout the entire period, highlighting Nike's ongoing focus on SG&A as the primary operating expense.